The joint report states that overall cancer rates have decreased for men, women, and children in all major race and ethnic groups. However, progress has been limited for some cancers.
Increase mainly due to papillary thyroid cancer, which increased in incidence for all SEER stages at diagnosis
Cancer deaths within 1 month of diagnosis occur most often in patients younger than 1 years, especially among Blacks and Hispanics.
Pregnancy around the time of, or after, diagnosis of breast cancer is not associated with an increased risk of death.
The Decipher genomic classifier obtained from biopsy samples was prognostic for distant metastases and prostate cancer-specific mortality.
NODA and V3 are volunteer programs that provide a compassionate presence for patients who are alone in their final hours.
Risk for all-cause mortality is lower among older women treated for DCIS.
Using statistical models, predictions were made for death rates from melanoma in 3 three countries and based on availability of a treatment.
Investigators determined the impact of socioeconomic status on disease status at presentation and survival among patients with head and neck squamous cell carcinoma.
Human metapneumovirus infections were associated with significant morbidity in patients with cancer; however, 30-day mortality rates were low.
A new study that only included women with a cervix has found the risk of dying from cervical cancer is higher than previously thought.
Cancer mortality rates in the United States have dropped, according to a new ACS report.
A twenty percent decrease in cancer death rate among children and adolescents has taken place from 1999 to 2014.
Low aerobic capacity has greater effect on longevity than even high cholesterol, or high blood pressure.
A study of nearly 1000 patients with HCC found that black patients with the disease had a 33% greater risk of death compared with non-Hispanic whites.
Research indicates that four key lifestyle factors contribute significantly to cancer mortality outcomes.
Previous Cancers Linked to Higher Rates for Death and New Cancers in Organ Transplantation RecipientsMay 06, 2016
People who had had cancer before an organ transplant are more likely to die of any cause or of cancer, or to develop a new cancer than people had not had cancer before an organ transplant.
The cancer death rate has dropped by 23% since its peak in 1991, averting more than 1.7 million cancer deaths through 2012, with advances in cancer prevention, early detection, and treatment a part of this rate decline.
Mortality rate changes in the United States since 1991 translate to an additional 1.7 million cancer survivors.
Cancer patients in their last weeks of life may have end-of-life experiences, including dreams and visions. A study from researchers at a hospice found that these events are an important part of a patient's dying process.
Cancer mortality in solid-organ transplant recipients (SOTRs) was increased compared with the cancer death rate expected in the general population.
More than 3 months from surgery to chemotherapy and increasing delays from diagnosis to surgery in patients with breast cancer are associated with increased risk of death from the disease.
Researchers estimate the 20-year breast cancer-specific death rate for women diagnosed with ductal carcinoma in situ to be 3.3%.
African American men are more likely to develop prostate cancer than European American men, and are also more than twice as likely to die from it.
Areas of the U.S. with higher colorectal cancer rates include parts of the Mississippi Delta, Appalachia, and eastern Virginia.
Age-adjusted prostate cancer-specific comorbidity index is strongly predictive of other-cause mortality, according to recent study data.
HIV has been linked to increased risk for colorectal, lung, skin, and breast cancers, independent of treatment.
Eighty percent of lung cancer deaths linked to smoking, researchers say, and the mortality rate of several other cancers is also strongly impacted by smoking status.
Fewer childhood cancer survivors die of 'late effects' from radiation and chemotherapy, according to recent research.
Post-diagnostic aspirin use is not associated with a decreased risk of prostate cancer outcomes, according to study data.
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Including a PI3-Kinase Inhibitor with an PARP Inhibitor Improves Tumor Shrinkage in Patients with Resistant Ovarian Cancer
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Shifts in Cancer Burden for People With HIV Projected
- Tissue Biobank Procurement Consent Should Include Discussion of Confidentiality Risks
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|